Relmada Therapeutics 미래 성장
Future 기준 확인 0/6
Relmada Therapeutics은 연간 수입과 매출이 각각 5.2%와 75.4% 증가할 것으로 예상되고 EPS는 연간 21.5%만큼 증가할 것으로 예상됩니다.
주요 정보
5.2%
수익 성장률
21.5%
EPS 성장률
| Pharmaceuticals 수익 성장 | 23.6% |
| 매출 성장률 | 75.4% |
| 향후 자기자본 수익률 | n/a |
| 애널리스트 커버리지 | Low |
| 마지막 업데이트 | 05 Nov 2024 |
최근 미래 성장 업데이트
Recent updates
Relmada Therapeutics: Run Up Into Results May Resume Following This Drop
Mar 21Here's Why We're Watching Relmada Therapeutics' (NASDAQ:RLMD) Cash Burn Situation
Mar 13
Relmada: Phase 3 Data Did Not Live Up To Phase 2 Benchmark
Jan 14Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Deliver On Growth Plans?
Dec 04Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Invest In Growth?
Aug 29We're Keeping An Eye On Relmada Therapeutics' (NASDAQ:RLMD) Cash Burn Rate
May 07We're Keeping An Eye On Relmada Therapeutics' (NASDAQ:RLMD) Cash Burn Rate
Dec 15Relmada Downgraded at Truist, Guggenheim in wake of depression candidate failure
Oct 14Relmada Therapeutics: Initiating With A Strong BUY; Key Phase 3 Short-Term Catalysts Lined Up
Sep 14Relmada Therapeutics receives FDA fast track tag for REL-1017 to treat depression
Aug 09We're Hopeful That Relmada Therapeutics (NASDAQ:RLMD) Will Use Its Cash Wisely
Jul 14Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Deliver On Growth Plans?
Feb 264 Clinical Catalysts On Tap For Relmada In 2022
Jan 28Is Relmada Therapeutics (NASDAQ:RLMD) In A Good Position To Invest In Growth?
Nov 04Our First Look At Relmada Therapeutics
Jun 28We're Not Very Worried About Relmada Therapeutics' (NASDAQ:RLMD) Cash Burn Rate
Jun 28Here's Why We're Not Too Worried About Relmada Therapeutics' (NASDAQ:RLMD) Cash Burn Situation
Mar 09What Percentage Of Relmada Therapeutics, Inc. (NASDAQ:RLMD) Shares Do Insiders Own?
Jan 15
Enrollment underway in Relmada Therapeutics' late-stage depression study with REL-1017
Dec 07Relmada Therapeutics (RLMD) Investor Presentation - Slideshow
Dec 02Relmada Therapeutics (RLMD) Investor Presentation - Slideshow
Nov 16수익 및 매출 성장 예측
| 날짜 | 수익 | 수익 | 잉여 현금 흐름 | 작전 현금 | 평균 애널리스트 수 |
|---|---|---|---|---|---|
| 12/31/2026 | 20 | -131 | -69 | N/A | 3 |
| 12/31/2025 | N/A | -100 | -65 | N/A | 3 |
| 12/31/2024 | N/A | -82 | -55 | N/A | 3 |
| 6/30/2024 | N/A | -87 | -48 | -48 | N/A |
| 3/31/2024 | N/A | -94 | -48 | -48 | N/A |
| 12/31/2023 | N/A | -99 | -52 | -52 | N/A |
| 9/30/2023 | N/A | -112 | -77 | -77 | N/A |
| 6/30/2023 | N/A | -129 | -93 | -93 | N/A |
| 3/31/2023 | N/A | -144 | -101 | -101 | N/A |
| 12/31/2022 | N/A | -157 | -104 | -104 | N/A |
| 9/30/2022 | N/A | -153 | -106 | -106 | N/A |
| 6/30/2022 | N/A | -157 | -100 | -100 | N/A |
| 3/31/2022 | N/A | -143 | -95 | -95 | N/A |
| 12/31/2021 | N/A | -126 | -92 | -92 | N/A |
| 9/30/2021 | N/A | -112 | -61 | -61 | N/A |
| 6/30/2021 | N/A | -86 | -53 | -53 | N/A |
| 3/31/2021 | N/A | -71 | -40 | -40 | N/A |
| 12/31/2020 | N/A | -59 | -28 | -28 | N/A |
| 9/30/2020 | N/A | -43 | -25 | -25 | N/A |
| 6/30/2020 | N/A | -30 | -15 | -15 | N/A |
| 3/31/2020 | N/A | -23 | -14 | -14 | N/A |
| 12/31/2019 | N/A | -15 | -12 | -12 | N/A |
| 9/30/2019 | N/A | -18 | -11 | -11 | N/A |
| 6/30/2019 | N/A | -17 | -10 | -10 | N/A |
| 3/31/2019 | N/A | -17 | -9 | -9 | N/A |
| 12/31/2018 | N/A | -17 | -9 | -9 | N/A |
| 9/30/2018 | N/A | -11 | -7 | -7 | N/A |
| 6/30/2018 | N/A | -9 | -6 | -6 | N/A |
| 3/31/2018 | N/A | -7 | N/A | -5 | N/A |
| 12/31/2017 | N/A | -6 | N/A | -5 | N/A |
| 9/30/2017 | N/A | -6 | N/A | -5 | N/A |
| 6/30/2017 | N/A | -6 | N/A | -6 | N/A |
| 3/31/2017 | N/A | -8 | N/A | -8 | N/A |
| 12/31/2016 | N/A | -8 | N/A | -10 | N/A |
| 9/30/2016 | N/A | -9 | N/A | -12 | N/A |
| 6/30/2016 | N/A | -3 | N/A | -13 | N/A |
| 3/31/2016 | N/A | 6 | N/A | -15 | N/A |
| 12/31/2015 | N/A | 6 | N/A | -16 | N/A |
| 9/30/2015 | N/A | 14 | N/A | -17 | N/A |
| 6/30/2015 | N/A | -21 | N/A | -16 | N/A |
| 3/31/2015 | N/A | -55 | N/A | -13 | N/A |
| 12/31/2014 | N/A | -46 | N/A | -9 | N/A |
| 9/30/2014 | N/A | -56 | N/A | -5 | N/A |
| 6/30/2014 | N/A | -28 | N/A | -3 | N/A |
| 3/31/2014 | N/A | -13 | N/A | -3 | N/A |
애널리스트 미래 성장 예측
수입 대 저축률: RLMD 향후 3년 동안 수익성이 없을 것으로 예상됩니다.
수익 vs 시장: RLMD 향후 3년 동안 수익성이 없을 것으로 예상됩니다.
고성장 수익: RLMD 향후 3년 동안 수익성이 없을 것으로 예상됩니다.
수익 대 시장: RLMD 은(는) 내년에 수익이 없을 것으로 예상됩니다.
고성장 수익: RLMD 은(는) 내년에 수익이 없을 것으로 예상됩니다.
주당 순이익 성장 예측
미래 자기자본 수익률
미래 ROE: RLMD 의 자기자본수익률이 3년 내에 높을 것으로 예상되는지 판단하기에는 데이터가 부족합니다.